The story of Sildenafil offers a complex case study for stakeholders eyeing pharma. While early sales were explosive, present patent expiration and the rise of generic versions have significantly influenced https://chiaraeduv064601.blog-mall.com/41826420/the-blue-pill-and-pharma-a-dangerous-stake